AlphaCrest Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-51,696
| Closed | -$633K | – | 351 |
|
|
2022
Q3 | $633K | Buy |
51,696
+37,595
| +267% | +$460K | 0.04% | 871 |
|
|
2022
Q2 | $167K | Sell |
14,101
-11,052
| -44% | -$131K | 0.01% | 1216 |
|
|
2022
Q1 | $478K | Buy |
25,153
+2,760
| +12% | +$52.5K | 0.03% | 917 |
|
|
2021
Q4 | $595K | Buy |
22,393
+11,057
| +98% | +$294K | 0.02% | 1035 |
|
|
2021
Q3 | $466K | Buy |
+11,336
| New | +$466K | 0.02% | 948 |
|
|
2021
Q2 | – | Sell |
-8,100
| Closed | -$340K | – | 1249 |
|
|
2021
Q1 | $340K | Buy |
8,100
+3,200
| +65% | +$134K | 0.02% | 967 |
|
|
2020
Q4 | $344K | Sell |
4,900
-3,800
| -44% | -$267K | 0.03% | 848 |
|
|
2020
Q3 | $244K | Buy |
+8,700
| New | +$244K | 0.03% | 966 |
|
|
2019
Q4 | – | Sell |
-23,900
| Closed | -$543K | – | 1272 |
|
|
2019
Q3 | $543K | Sell |
23,900
-30,200
| -56% | -$686K | 0.03% | 868 |
|
|
2019
Q2 | $1.34M | Buy |
54,100
+35,100
| +185% | +$868K | 0.12% | 269 |
|
|
2019
Q1 | $465K | Buy |
+19,000
| New | +$465K | 0.07% | 488 |
|